Policy innovation and dual-drive domestic surgical robot commercialization accelerated.

Recently, there have been frequent positive developments in the field of surgical robots, with continuous policy support and highlighted innovative achievements from enterprises, showing strong momentum in the industry. The "Several Measures to Support the High-Quality Development of Innovative Medicine in Beijing" issued by the Beijing Medical Insurance Bureau and other ten departments propose to promote the use of surgical robots in hospitals. The Hunan Provincial Medical Insurance Bureau recently clarified the charging standards for surgical robots and related auxiliary operations. At the 93rd China International Medical Equipment Exhibition held recently, companies such as Micro-invasive Robots and Tongdao Medical showcased their star products of endoscopes and orthopedic surgical robots, highlighting the innovative strength of domestic products. Industry insiders believe that surgical robots offer significant clinical benefits, and the global penetration rate is expected to continue to increase. Domestic manufacturers' products have clinical data comparable to da Vinci surgical robots, and the advantages of China's manufacturing industry bring higher cost-effectiveness, making it possible to seize global market share with differentiation advantages.